SAME FACTS. OPPOSITE SPIN.

IS IT TRUMP’S FAULT?

Antidepressant escitalopram more effective at preventing relapse, analysis finds

VOTING CLOSED

Voting on: Antidepressant escitalopram more effective at preventing relapse, analysis finds

Poll

All Responses

Hung jury.

Yes, it's Trump's fault

0%

No, it's not Trump's fault

0%

Too soon to tell

0%

0 verified votes

Yes, it's Trump's fault

The prosecution's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme prosecution of the sourced event.

No, it's not Trump's fault

The defense's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme defense of the sourced event.

Read what happened. Then watch the spinning begin. Facts first

Case F4BB39DBBEB5DFFA5C6B · 2026-11-11

The Trump Jury

Antidepressant escitalopram more effective at preventing relapse, analysis finds

Read both sides. Cast your verdict. Predict the crowd.

  1. 1 Case
  2. 2 Verdict
  3. 3 Prediction
  4. 4 Results

Step 1

Read the case

Neutral facts

Three pills came top and outperformed Prozac for preventing relapse in a large number of patients.

What the record shows: Three pills came top and outperformed Prozac for preventing relapse.

ProsecutionSatire

The prosecution's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme prosecution of the sourced event.

Read the full prosecution

Opening Argument

The prosecution argues that the recent findings on escitalopram's effectiveness are not just a medical breakthrough but a sinister plot that connects back to the Trump administration's policies on mental health. The prosecution alleges that the rise of this new antidepressant is a direct result of the chaos and instability fostered during Trump's presidency.

Exhibit A: The Plausible Link

The prosecution submits that the increased reliance on escitalopram is a reflection of the mental health crisis exacerbated by Trump's divisive rhetoric.

The Domino Effect

The prosecution imagines a world where this dependency spirals out of control, leading to a society that is medicated into submission.

The Hidden Danger

The prosecution urges that while escitalopram may prevent relapse, it also masks the underlying issues caused by Trump's policies, leading to a future where citizens are too medicated to fight back.

Closing Argument

In the prosecution's theory, the rise of escitalopram is not just a medical advancement but a reflection of the societal decay initiated by Trump.

Verdict

The prosecution alleges: The prosecution concludes that this is yet another example of how Trump's legacy continues to haunt the American people, even in their mental health treatments.

Prosecution exhibits

  1. Prosecution theory: Escitalopram's rise is linked to Trump's mental health crisis.
  2. Prosecution theory: Increased dependency on medications benefits pharmaceutical companies.
  3. Prosecution theory: This dependency leads to a medicated society unable to resist.

Reality Check

Three pills came top and outperformed Prozac for preventing relapse in a large number of patients.

DefenseSatire

The defense's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme defense of the sourced event.

Read the full defense

The Result

The defense might argue: Ladies and gentlemen of the jury, the recent analysis showing escitalopram's effectiveness in preventing relapse is a monumental victory for mental health treatment. The defense submits that this breakthrough offers hope to countless individuals struggling with depression.

What Trump Did

The defense might argue that the focus on mental health during Trump's administration laid the groundwork for these advancements.

Why Supporters Credit Him

Supporters might argue that this analysis reflects a broader trend of improving mental health care, which began during Trump's term. The defense admits that while Trump may not have directly influenced this specific study, his policies contributed to a more open dialogue about mental health.

The Supporting Record

The defense might suggest that the rise of escitalopram and its effectiveness is a testament to the ongoing evolution of antidepressants, showcasing the importance of continued research and development.

The Limitation or Competing Explanation

However, the defense might argue that while escitalopram is effective, it is essential to recognize that many factors contribute to mental health outcomes, including societal changes and increased awareness.

Verdict

If this is Trump's fault, his supporters will gladly let him take the blame.

Defense exhibits

  1. Supporters' theory: Escitalopram's rise is a victory for mental health treatment.
  2. Supporters' theory: Trump's focus on healthcare opened doors for advancements.
  3. Supporters' theory: This analysis reflects a broader trend of improving mental health care.

Reality Check

Three pills came top and outperformed Prozac for preventing relapse in a large number of patients.

Satirical commentary based on the sourced facts above. Not a news report, campaign, or endorsement.

Connecting to the jury room…

Final verdict announced: November 12, 2026 at 5:01 AM ET

Step 2 · Personal verdict

Your verdict

Cast your verdict in the POLL above. Then predict the jury here.

No account required. One active verdict per browser; you can change it while voting is open.

Your jury record

This browser

Cases judged
0
Average accuracy
—
Current streak
0